TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Rates of Readmissions
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Rates of Emergency Department Visit
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: detrusor overactivity (DO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: bladder compliance (BC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Success passage rate at the first attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Epworth sleeping scale (ESS)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Monocyte mitochondrial respiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to transfer decision
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of women who have a response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Adult Participants With Solicited Local Adverse Events (AEs) for 7 Days Post First Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Adult Participants With Solicited Systemic AEs for 7 Days Post First Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Adult Participants With Serious Adverse Events (SAEs) From First Vaccination Until End of the Study (EOS)
Endpoint domain: Adverse events/effects
Primary endpoint: Pinch meter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: The American Spinal Injury Association Impairment Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Graded redefined assessment for sensation, strength and prehension tool
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: walking speed (m/s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: swing phase asymmetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stride length asymmetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Faecal calprotectin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Faecal lactoferrin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Blood IgAs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Efficacy of noninvasive respiratory support
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Consistency between AI and human expert scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: modified Genetic Counselling Scale - 24 (mGCOS-24)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: lymph node metastasis status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cmax of dextromethorphan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t of dextromethorphan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-24 of dextromethorphan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to daily exercise goals
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean Change of Ocular Axial length elongation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction after the procedure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: functionallity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Routine blood test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Routine urine test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Liver renal function test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in Physical Status as assessed by the 6 minute walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Cognitive Status as assessed by the Montreal Cognitive Assessment (MoCA)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Health related quality of life as assessed by the Short Form 8 (SF-8) Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Postural Sway Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation of Respiratory Function Test Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Evaluation of Archery Shooting Performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: foot disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Muscle Strength-Endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total dose of pethidine consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in lumbar and femoral t-score bone mineral density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sustained Nausea and Vomiting Relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Development of New Symptom
Endpoint domain: Adverse events/effects
Primary endpoint: Unacceptable toxicity rate
Endpoint domain: Adverse events/effects
Primary endpoint: Landmark survival analyses
Endpoint domain: Mortality/survival
Primary endpoint: Carotid artery wall thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Tampa Scale of Kinesiophobia (TSK) scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Recurrence of atrial arrhythmias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: frequency of sexual intercourse
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in ALSFRS-R decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of New HO Lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor Maximal Diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: T cell immunodeficiency characterization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: first major or clinically relevant non-major bleeding event
Endpoint domain: Adverse events/effects
Primary endpoint: total morphine milliequivalents (MME)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity of the iStatis Syphilis Ab Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Perceptual femininity/masculinity score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intratumoral changes of PD-L1 expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement of major Low Anterior Resection Syndrome (LARS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Steady state whole blood trough concentration of tacrolimus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to complete web-based electronic questionnaires
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Continuous retention of patients completing electronic data
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Fugl-Meyer Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Tinetti Balance & Gait Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-suicidal self-injury assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Natural killer (NK) cell killing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rate of complete colonoscopies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Exercise Tolerance Test (ETT) duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in faecal microbiota composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Increase of secondary bile acids production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in immune cell expression of HIF1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Immune cell densities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction of hemoglobin A1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Annualized Infection Rate
Endpoint domain: Adverse events/effects
Primary endpoint: Positive Absolute Neutrophil Count (ANC) Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of participants with A1c <6.5%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: femoral artery and femoral nerve distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EQ-5D-5L Quality of Life Visual Result
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in self-reported pain score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Scoliosis progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to the Program
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Accuracy of the system compared to gold standard ECG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of the sensor as viewed by the parent
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CGM Reading
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fingerstick point of care glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hierarchical composite of all-cause death
Endpoint domain: Mortality/survival
Primary endpoint: Unplanned hospital visit/readmission for cardiac reasons
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of Participants in Clinical Response at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to full alertness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to peak sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Treatment Emergent Adverse Effects
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With HLA A Genotypes Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Frailty Change (baseline to post exercise intervention)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chemotherapy completion rates (End of Cycle 1)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Pain Unpleasantness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: RIVT symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Student Satisfaction and Self-Confidence Scale in Learning
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Simulation Design Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feeling lucidity
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Feeling fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: acceptable pain control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acceptable quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: acceptable joint functionality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Tissue frataxin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Repetitive tachycardia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Presence or absence of interstitial lung disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: CBC with leukocyte formula and calculation of the NLR and PLR ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Occurrence of arterial and venous thrombotic events
Endpoint domain: Adverse events/effects
Primary endpoint: Estimated volume of intraoperative blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Oncological effectiveness defined as treatment failure
Endpoint domain: Mortality/survival
Primary endpoint: Quality of life measured with Functional Assessment of Cancer Therapy-Prostate questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Experienced Integration Scale (EIS)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Vaccination coverage rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in adolescent depressive symptom severity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Perceptions of insulin delivery systems
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rates of post-operative complications
Endpoint domain: Adverse events/effects
Primary endpoint: time to Emax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of encounters tapering within CDC guidelines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Color Word Stroop Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Malignant Ventricular Arrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Patient-related medication errors or misuse
Endpoint domain: Adverse events/effects
Primary endpoint: Feasibility of Y-90 TARE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Safety of Y-90 TARE
Endpoint domain: Adverse events/effects
Primary endpoint: Uterine incision extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Participants With Adverse Events (AEs) and Serious AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Pharmacokinetics (PK) of ASP2215 in plasma: concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identifying immune-related epigenetic modifications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Identifying immune-related modifications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Identifying patient symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Vocal emotion recognition accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vocal emotion recognition sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recognition of recorded speech emotions by listeners -- percent correct scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of disability and quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Therapeutic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Quality of life post fat grafting
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Post intervention effect
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Follow up intervention effect
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Average kcals per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time in moderate to vigorous physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 4 mm high-order corneal aberrations (Hoa) in Microns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 4 mm high-order strehl ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spherical Aberrations (SA) in Microns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait analysis differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy difference between groups
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with positive cultures
Endpoint domain: Adverse events/effects
Primary endpoint: differences of DNA methylation in granulosa cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: differences of DNA methylation in peripheral venous blood of patients undergoing ART
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: impact of exogenous pro-inflammatory factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Scale for Suicidal Ideation Remission
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: disorders of glucose metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: rates of overweight and obesity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: risk of hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: adiposity in offspring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Quality of life related to stroke
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Sexual Interest and Desire Inventory-Female (SIDI-F)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: cerebral tissue oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: percentage of patients with sustained improvement based on MG-ADL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Childhood-asthma control test (C-ACT)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: maximum diameters of the levator hiatus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pubovisceral muscle thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy validation - heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Accuracy validation - pulse oximetry for peripheral venous blood oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy validation - temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Sensory Processing Scale Inventory (SPSI) scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical spectrum of infants of diabetic mothers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radioactivity concentration (SUVmean, %ID/g) of BAY3630942 in normal organs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Zirconium-89 absorbed doses (mGy/MBq) in normal organs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absorbed doses (mGy/MBq) from actinium-225 and daughter radionuclides in critical organs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PrEP Use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of patients with grade 2 or higher post-operative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Percent decrease of phosphorylated CDK1 and/or Ki67, or p-HH3, or p-CHK1 in tumor cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Frequency of IFX discontinuation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Need for treatment intensification due to non-response or LOR
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Changes in Abdominal Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pathologically negative MRI-guided biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in clinESSDAI Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intervention acceptability (engagement with intervention)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intervention acceptability (subjective experience)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status